Planta Med 2022; 88(09/10): 702-720
DOI: 10.1055/a-1795-0562
Biological and Pharmacological Activity
Reviews

Biological Dark Matter Exploration using Data Mining for the Discovery of Antimicrobial Natural Products[ # ]

Autor*innen

  • José Rivera-Chávez

    1   Instituto de Química, Universidad Nacional Autónoma de México, Ciudad de México, México
  • Corina-Diana Ceapă

    1   Instituto de Química, Universidad Nacional Autónoma de México, Ciudad de México, México
  • Mario Figueroa

    2   Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México

Gefördert durch: Consejo Nacional de Ciencia y Tecnología CF-263977 Gefördert durch: Facultad de Química, Universidad Nacional Autonoma de México PAIP 5000-9145 Gefördert durch: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México PAPIIT IA201721 Gefördert durch: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México PAPIIT IA203220 Gefördert durch: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México PAPIIT IN222220

Abstract

The discovery of novel antimicrobials has significantly slowed down over the last three decades. At the same time, humans rely increasingly on antimicrobials because of the progressive antimicrobial resistance in medical practices, human communities, and the environment. Data mining is currently considered a promising option in the discovery of new antibiotics. Some of the advantages of data mining are the ability to predict chemical structures from sequence data, anticipation of the presence of novel metabolites, the understanding of gene evolution, and the corroboration of data from multiple omics technologies. This review analyzes the state-of-the-art for data mining in the fields of bacteria, fungi, and plant genomic data, as well as metabologenomics. It also summarizes some of the most recent research accomplishments in the field, all pinpointing to innovation through uncovering and implementing the next generation of antimicrobials.

# Dedicated to Professor Dr. A. Douglas Kinghorn on the occasion of his 75th birthday.


Supporting Information



Publikationsverlauf

Eingereicht: 21. Dezember 2021

Angenommen nach Revision: 03. März 2022

Artikel online veröffentlicht:
13. Juni 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany